World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
52
Citations
8275
World Ranking
4245
National Ranking
130

Carmen de Mendoza publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Carmen de Mendoza sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 254 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Carmen de Mendoza D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Carmen de Mendoza sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 52 D-Index — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Carmen de Mendoza is affiliated with the Instituto de Salud Carlos III in Spain and has contributed extensively to the field of medicine, particularly focusing on infectious diseases and epidemiology. Their body of work spans several subfields, including hepatology, immunology, and agronomy and crop science.

Their research topics prominently include hepatitis C virus research, T-cell and retrovirus studies, hepatitis B virus studies, and SARS-CoV-2 and COVID-19 research. Additional focus areas are COVID-19 clinical research studies, long-term effects of COVID-19, and animal disease management and epidemiology.

Recent papers published by Carmen de Mendoza include:

  • Main differences between the first and second waves of COVID-19 in Madrid, Spain (2021) published in International Journal of Infectious Diseases
  • Third wave of COVID-19 in Madrid, Spain (2021) published in International Journal of Infectious Diseases
  • Bacterial infections in patients hospitalized with COVID-19 (2021) published in Internal and Emergency Medicine
  • Advances in hepatitis B therapeutics (2020) published in Therapeutic Advances in Infectious Disease
  • Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain (2021) published in International Journal of Infectious Diseases

Their frequent coauthors consist of Vincent Soriano, Víctor Moreno-Torres, Octavio Corral, Pablo Barreiro, and Ana Treviño.

The scientist often publishes in venues such as Aids Reviews, International Journal of Infectious Diseases, Journal of Clinical Virology, AIDS, and Liver International. Among these, Aids Reviews and International Journal of Infectious Diseases have been particularly prominent outlets for their work.

Best Publications

  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

    Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  • Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

    L. Marije Hofstra;Nicolas Sauvageot;Jan Albert;Jan Albert;Ivailo Alexiev

  • Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

    Dimitrios Paraskevis;Dimitrios Paraskevis;Oliver Pybus;Gkikas Magiorkinis;Angelos Hatzakis

  • Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy.

    Pablo Barreiro;Jorge del Romero;Manuel Leal;Victoria Hernando

  • Impact of Human Immunodeficiency Virus Type 1 (HIV-1) Genetic Diversity on Performance of Four Commercial Viral Load Assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT

    Priscilla Swanson;Carmen de Mendoza;Yagnya Joshi;Alan Golden

  • Evaluation of Eight Different Bioinformatics Tools To Predict Viral Tropism in Different Human Immunodeficiency Virus Type 1 Subtypes

    Carolina Garrido;Vanessa Roulet;Natalia Chueca;Eva Poveda

  • The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy.

    Pillay D;Bhaskaran K;Jurriaans S;Prins M

  • The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

    David A van de Vijver;Annemarie M J Wensing;Gioacchino Angarano;Birgitta Asjö

  • Dried Blood Spots Perform Well in Viral Load Monitoring of Patients Who Receive Antiretroviral Treatment in Rural Tanzania

    Asgeir Johannessen;Carolina Garrido;Natalia Zahonero;Leiv Sandvik

  • Main differences between the first and second waves of COVID-19 in Madrid, Spain.

    Vicente Soriano;Pilar Ganado-Pinilla;Miguel Sánchez-Santos;Felix Gómez-Gallego

  • Hepatitis Delta Is a Major Determinant of Liver Decompensation Events and Death in HIV-Infected Patients

    José Vicente Fernández-Montero;Eugenia Vispo;Pablo Barreiro;Rocío Sierra-Enguita

  • Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.

    Bernard Masquelier;Krishnan Bhaskaran;Deenan Pillay;Robert Gifford

  • Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial

    Vincent Soriano;Pilar Garcia-Gasco;Eugenia Vispo;Andrés Ruiz-Sancho

  • Correlation between Human Immunodeficiency Virus Type 1 (HIV-1) RNA Measurements Obtained with Dried Blood Spots and Those Obtained with Plasma by Use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV Load Tests

    Carolina Garrido;Natalia Zahonero;Angélica Corral;Miguel Arredondo

  • Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades

    Tomas Doyle;David T. Dunn;Francesca Ceccherini-Silberstein;Carmen De Mendoza

  • Drug resistance in patients experiencing early virological failure under a triple combination including indinavir.

    Oscar Gallego;Carmen De Mendoza;Maria Jesus Perez-Elias;Josep Maria Guardiola

  • High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients

    Silvina Masciotra;Carolina Garrido;Ae S Youngpairoj;Amanda McNulty

  • Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance

    Carmen de Mendoza;Carmen Rodriguez;Federico García;José M Eiros

  • High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists

    Eduardo Seclén;Carolina Garrido;María del Mar González;Juan González-Lahoz

  • Plasmid-determined resistance to fosfomycin in Serratia marcescens.

    C Mendoza;J M Garcia;J Llaneza;F J Mendez

  • Resistance to Nonnucleoside Reverse-Transcriptase Inhibitors and Prevalence of HIV Type 1 Non-B Subtypes Are Increasing among Persons with Recent Infection in Spain

    Carmen de Mendoza;Carmen Rodriguez;Javier Colomina;Concepción Tuset

Frequent Co-Authors

Vincent Soriano
Vincent Soriano Universidad Internacional De La Rioja
Pablo Barreiro
Pablo Barreiro Hospital Universitario La Paz
Pablo Labarga
Pablo Labarga Instituto de Salud Carlos III
Juan González-Lahoz
Juan González-Lahoz Instituto de Salud Carlos III
José Ramos
José Ramos University of Córdoba
Luz Martín-Carbonero
Luz Martín-Carbonero Hospital Universitario La Paz
Marina Núñez
Marina Núñez Wake Forest University
Dimitrios Paraskevis
Dimitrios Paraskevis National and Kapodistrian University of Athens
Francisco J. Blanco
Francisco J. Blanco University of A Coruña
Kholoud Porter
Kholoud Porter University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a variety of career paths and further educational opportunities, many of which can be pursued online. For individuals facing unique challenges, such as those re-entering the workforce, there are options like online colleges that accept felons, providing a fresh start alongside valuable knowledge in the sciences.

Healthcare is a prominent field where microbiology graduates can thrive. Becoming a functional nurse practitioner integrates microbiology principles with patient-centered care, emphasizing holistic treatment approaches.

Alternatively, those interested in the intersection of healthcare and technology might pursue certifications like the certified professional coder certification. This path leverages analytical skills essential for accurate medical coding and billing, a critical aspect of healthcare management.

Finally, advancing in healthcare administration through a master in health information management salary programs can lead to rewarding roles managing complex health data systems—key for modern medical facilities.

Best Scientists Citing Carmen de Mendoza

Trending Scientists